Loading...
Intravitreal bevacizumab as an adjunct in the management of a vascular choroidal granuloma
A 43-year-old woman with tubercular choroidal granuloma showed poor response to conventional first-line four-drug antitubercular therapy (ATT) and corticosteroids. A therapeutic trial with intravitreal bevacizumab (1.25 mg in 0.05 mL) injections as an adjunct to ATT and corticosteroids led to a prom...
Na minha lista:
| Main Authors: | , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BMJ Publishing Group
2013
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3794147/ https://ncbi.nlm.nih.gov/pubmed/24014333 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2013-200255 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|